title: Risk stratification of patients with IgA nephropathy.
abstract: In this review, we summarize recent advances in the risk stratification of patients with immunoglobulin A (IgA) nephropathy. Several clinical variables have consistent and independent associations with worse kidney prognosis, including blood pressure, proteinuria, and baseline kidney function. Although one-time cross-sectional assessments of blood pressure and proteinuria are important, a more thorough understanding of risk can be achieved when these variables are considered over a follow-up period. IgA nephropathy is unique compared with other glomerular diseases in that a much lower threshold of proteinuria (protein excretion, 1 g/d) is associated with glomerular filtration rate (GFR) loss. Controlling proteinuria and blood pressure over time is important to reduce the risk of future loss of kidney function. The recently described Oxford classification has helped standardize the pathologic characterization of IgA nephropathy using a scoring system that is readily reproducible and associated with increased risk of GFR loss independent of clinical variables. We suggest an approach to risk stratification in IgA nephropathy when considering potential treatment with immunosuppression. Despite our current understanding of risk stratification in IgA nephropathy, the ability to accurately predict individual patient-level risk currently is limited, and further research into additional biomarkers or risk prediction tools is needed to improve the care of patients with IgA nephropathy.
authors.affiliation: Department of Medicine, Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.
authors.forename: Sean J
authors.initials: SJ
authors.lastname: Barbour
authors.forename: Heather N
authors.initials: HN
authors.lastname: Reich
mesh_terms: D002423:Cause of Death; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate / Q000502:physiology; D005922:Glomerulonephritis, IGA / Q000401:mortality* / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000209:etiology* / Q000401:mortality* / Q000628:therapy; D008297:Male; D011507:Proteinuria / Q000453:epidemiology / Q000503:physiopathology; D006435:Renal Dialysis / Q000379:methods / Q000401:mortality; D018570:Risk Assessment; D012720:Severity of Illness Index; D016019:Survival Analysis